Janssen Pharmaceuticals
Belgian pharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Janssen Pharmaceutica?
Summarize this article for a 10 year old
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.
Parts of this article (those related to weighing public health concerns with Janssen vaccine's crucial role in health equity and mitigating spread of SARS-CoV-2 spread and resulting mutations) need to be updated. (April 2021) |
Company type | Subsidiary |
---|---|
Industry | Pharmaceutical |
Founded | 1953; 71 years ago (1953) |
Founder | Paul Janssen |
Headquarters | Turnhoutseweg 30, , Belgium |
Area served | Worldwide |
Key people | Jennifer Taubert |
Number of employees | 45.000 |
Parent | Johnson & Johnson |
Website | www.janssen.com |
In 1961, Janssen Pharmaceuticals was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.